Status:
UNKNOWN
Intravitreal Bevacizumab for Management of Active Progressive Proliferative Diabetic Retinopathy (PDR)
Lead Sponsor:
Shahid Beheshti University of Medical Sciences
Conditions:
Diabetic Retinopathy
Eligibility:
All Genders
Phase:
PHASE3
Brief Summary
To evaluate the effect of intravitreal bevacizumab on the course of diabetic retinopathy in cases with the signs of active progressive PDR
Eligibility Criteria
Inclusion
- Cases of active progressive PDR with history of scatter laser photocoagulation
Exclusion
- history of vitrectomy
Key Trial Info
Start Date :
March 1 2006
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00370721
Start Date
March 1 2006
Last Update
June 26 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hamid Ahmadieh, MD
Tehran, Tehran Province, Iran, 16666